According to Precision Business Insights, the Poultry Drugs Market research report provides industry size and growth.
The Poultry Drugs Market size was valued at USD 5100 million in 2022 and is expected to grow at a CAGR of 9% from 2023-2029. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Poultry drugs are chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others.
The global poultry drugs market is divided into following categories.
And lastly, on the basis of geographical regions, the global poultry drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa regions. North America poultry anticoccidial drugs market is growing at a significant rate, which is attributed to rise in demand for healthy meat and poultry products, launching of newer products into the market, and increase in awareness about the poultry diseases. Europe poultry vaccines market has a lucrative growth owing to rise in prevalence of various diseases such as avian flu, rise in animal welfare expenditure, and increase in the R&D activities for the innovation of newer drugs are bolster the market. Asia Pacific poultry vaccines market is poised to grow at significant rate due to increase in trading of meat and other poultry products from India and China, rise in number of poultry farms, and adoption of newer drugs and vaccines. Latin America poultry antiviral drugs market is rising due to positive economic growth, rise in animal welfare expenditure, and launching of newer products by the companies in the region. Middle East and Africa poultry anticoccidial drugs market exhibiting a prominent growth rate owing to expansion of business by the market players, rise in prevalence of infectious diseases, and increase in awareness about poultry diseases are boost the market.
Some of the key players in the global poultry drugs market include Zoetis (Pfizer, Inc.) (U.S.), Merck & Co. Inc. (U.S), Virbac S.A. (France), Boehringer Ingelheim Vetmedica (Germany), Elanco (U.S.), Bayer Animal Health (Germany), Phibro Animal health Corporation (U.S.), Zydus AHL (India), Ceva Sante Animale (France).